Finally, copolymers hemo- and cytocompatibility were evaluated by hemagglutination, hemolysis, and cells proliferation tests. The results showed that the proposed cationic amphiphilic random ...

ImmuneOncia Therapeutics, Inc. (CEO Heung-Tae Kim) announced interim results today from the ongoing Phase 1b clinical trial ...

III Graduate student inVeterinary Medicine - Higiene Veterinária e Processamento de Produtos de Origem Animal, UFF, Niterói, RJ Correspondence Correspondence to Elmiro Rosendo Nascimento UFF - ...

The U.S. Department of Health and Human Services (HHS) has announced the termination of its contract with pharmaceutical ...

At baseline, pre-existing immunity was minimal, with only 2.1% of participants showing hemagglutination inhibition (HAI) antibody titers ≥1:40, an HAI titer considered to correlate with protection.

The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their ...

Institute of Molecular Pharmacy, Pharmacenter, University of Basel, Klingelbergstrasse 50, CH-4056 Basel, Switzerland *To whom correspondence should be addressed. Phone: +41 61 267 1551. Fax: +41 61 ...